icONE: The World's First AI-Powered Embryo Prediction System

AN-AN IVF Reproductive Medicine Group ,the Center for Genomic Medicine at National Cheng Kung University、and MedGene Biotechnology have collaborated to develop icONE, the world's first AI-powered embryo quality prediction system.
This system precisely integrates clinical information, embryonic differentiation data, and genetic sequencing analysis, utilizing AI algorithms to accurately evaluate embryo viability and quality, assisting clinicians in selecting optimal embryos for implantation and improving successful implantation rates.
 
This innovative technology has not only won the National Innovation Award but has also received FDA certification in the United States, establishing Taiwan's reproductive medical technology on the international stage and bringing a significant breakthrough to the field of reproductive medicine.